Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons
about
Stress in adolescence and drugs of abuse in rodent models: role of dopamine, CRF, and HPA axisDrug withdrawal conceptualized as a stressor.Stress and VTA synapses: implications for addiction and depressionAversive stimuli drive drug seeking in a state of low dopamine toneEthanol action on dopaminergic neurons in the ventral tegmental area: interaction with intrinsic ion channels and neurotransmitter inputs.Diversity of Dopaminergic Neural Circuits in Response to Drug ExposureCorticotropin releasing factor-induced CREB activation in striatal neurons occurs via a novel Gβγ signaling pathwayRole of corticotropin-releasing factor (CRF) receptor-1 on the catecholaminergic response to morphine withdrawal in the nucleus accumbens (NAc)Deletion of corticotropin-releasing factor binding protein selectively impairs maternal, but not intermale aggressionCorticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neuronsDistribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibresAugmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2Stress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nucleiLong-term potentiation (LTP) in the central amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptorsRole of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gatingStress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.Synaptic effects induced by alcohol.Don't stress about CRF: assessing the translational failures of CRF1antagonists.The role of PKC signaling in CRF-induced modulation of startle.Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA.Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs.Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process.Identification of brain target neurons using a fluorescent conjugate of corticotropin-releasing factor.AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli.Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcersCorticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.Defining the role of corticotropin releasing factor binding protein in alcohol consumption.Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administrationNeurobiological mechanisms of addiction: focus on corticotropin-releasing factor.A ventral tegmental CRF-glutamate-dopamine interaction in addiction.Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: Focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin.CRF-R2 and the heterosynaptic regulation of VTA glutamate during reinstatement of cocaine seeking.Intrinsic neuronal plasticity in the juxtacapsular nucleus of the bed nuclei of the stria terminalis (jcBNST)Stress-induced cocaine seeking requires a beta-2 adrenergic receptor-regulated pathway from the ventral bed nucleus of the stria terminalis that regulates CRF actions in the ventral tegmental area.Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodelingDynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanismsHeterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties.
P2860
Q26826877-29BB0607-B3DA-4444-A343-C11ED3E0F681Q26997989-DDA6C63B-1C70-465B-9913-EA21CA956ABFQ26999218-BA6A3027-2521-442B-9269-7B325EB56658Q27327277-4E2A272A-8958-4D17-A624-3579A86F397AQ27687624-DB5ABD76-6B41-4475-B2A6-0F0FA6921C95Q28067590-34C96B0C-C102-4BEB-9683-211BE7D6B9DAQ28477480-0AB90BCE-61B4-45C8-819D-086FE7E5A21EQ28484325-1ECABB26-B46A-44C7-BF76-1F07F7852157Q28507836-A696A4E5-8A1C-434F-8C57-619587163D96Q28568495-95898751-7164-44B4-A102-BD4F64E32AD1Q28573727-179AB310-457B-41E2-B1C0-E85A82E13559Q28573866-44EC77DC-5662-4FCA-AA21-CCDA5D103706Q28573964-76031217-D919-4A65-9F20-294C0C338F64Q28582681-22D5D6B6-3581-48CE-A601-E2D9946DD289Q28589225-CDECB984-D07F-429A-B896-446BB8AB1BFDQ30366964-A2989A98-777C-4BF0-8FDD-98C40550A2E2Q30388351-613EC1B1-0FDD-4E50-85B0-0EA1DD839AFEQ30399543-C6FD1DC2-5FF4-4C29-82DE-E37A3C0A26D1Q30429995-EFC7AF1F-9C3C-423F-9841-B5BE9EDADE8BQ30461988-7D359BE4-BA8F-4C59-861C-EF978D7777E9Q30475129-E0F7D05C-CDEA-47C7-A717-E3EE3A7C982FQ30487401-78A2B1E9-19ED-4AFA-AC36-4AD732D526B7Q30488917-44A99AAE-D612-41B6-9882-DC2A12982425Q30489768-051AB8E0-EF68-4FE7-8EB9-C6B6353A40E4Q30490140-1557A6AE-8BDC-4A2E-8826-715E5EE06668Q30491390-82DE1DC3-C909-4A0F-ABC1-4397E57FA179Q30502566-8DF17DD9-C235-4E2B-9E67-6BC54C0353BBQ30838960-1B49C313-A377-4E87-BFCF-559B57E84423Q33381613-5BB00DFF-CA67-4A60-89EB-557DD2087186Q33455500-FF25C96D-B4AE-4883-8660-B2B01CC869C7Q33575214-62289B05-8DBC-464B-89EC-A1A92AFB4AD6Q33616639-13A7AAD4-EF4A-46B7-AB96-C9CFB8ACE349Q33643410-8A2A9787-9050-445F-B883-81BF780D82F5Q33643476-5D68AFA9-4D7A-459B-B349-2838A544A1DBQ33969858-EBC9CEC7-9A30-437E-A8FD-0F67111D3E46Q34109719-76BAD8CC-88EF-4D0E-8E55-E10A1D9470CCQ34162794-BAA3E936-C7BF-4075-8BF0-A1E8BED5E8C9Q34166000-DD914822-E36B-489A-AFB4-B500588D929DQ34211245-74466D6D-2F84-45BB-B944-9B1DE129AE5EQ34394879-CA0373C9-8EB6-4DFF-9EB2-AAD3FC45582E
P2860
Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@ast
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@en
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@en-gb
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@nl
type
label
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@ast
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@en
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@en-gb
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@nl
prefLabel
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@ast
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@en
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@en-gb
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@nl
P2093
P921
P3181
P1433
P1476
Corticotropin-releasing factor ...... receptor 2 in dopamine neurons
@en
P2093
Antonello Bonci
Tara L Crowder
Vineeta Singh
P304
P3181
P356
10.1016/S0896-6273(03)00461-6
P407
P577
2003-07-01T00:00:00Z